BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sabin A, Boulger L. History of Sabin attenuated poliovirus oral live vaccine strains. Journal of Biological Standardization 1973;1:115-8. [DOI: 10.1016/0092-1157(73)90048-6] [Cited by in Crossref: 244] [Cited by in F6Publishing: 135] [Article Influence: 5.1] [Reference Citation Analysis]
Number Citing Articles
1 Manuelidis L. Dementias, neurodegeneration, and viral mechanisms of disease from the perspective of human transmissible encephalopathies. Ann N Y Acad Sci 1994;724:259-81. [PMID: 8030947 DOI: 10.1111/j.1749-6632.1994.tb38916.x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 15] [Article Influence: 0.9] [Reference Citation Analysis]
2 Kew OM, Pallansch MA, Omilianowski DR, Rueckert RR. Changes in three of the four coat proteins of oral polio vaccine strain derived from type 1 poliovirus. J Virol 1980;33:256-63. [DOI: 10.1128/jvi.33.1.256-263.1980] [Cited by in Crossref: 35] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
3 Pelletier I, Ouzilou L, Arita M, Nomoto A, Colbère-Garapin F. Characterization of the poliovirus 147S particle: new insights into poliovirus uncoating. Virology 2003;305:55-65. [PMID: 12504541 DOI: 10.1006/viro.2002.1736] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
4 Georgescu MM, Delpeyroux F, Tardy-panit M, Balanant J, Combiescu M, Combiescu AA, Guillot S, Crainic R. High diversity of poliovirus strains isolated from the central nervous system from patients with vaccine-associated paralytic poliomyelitis. J Virol 1994;68:8089-101. [DOI: 10.1128/jvi.68.12.8089-8101.1994] [Cited by in Crossref: 85] [Cited by in F6Publishing: 40] [Article Influence: 3.1] [Reference Citation Analysis]
5 Ellis RW, Brown KR. Combination vaccines. Adv Pharmacol 1997;39:393-423. [PMID: 9160121 DOI: 10.1016/s1054-3589(08)60077-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
6 Liebert UG. Slow and persistent virus infections of neurones--a compromise for neuronal survival. Curr Top Microbiol Immunol 2001;253:35-60. [PMID: 11417139 DOI: 10.1007/978-3-662-10356-2_3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
7 Yoneyama T, Hagiwara A, Hara M, Shimojo H. Alteration in oligonucleotide fingerprint patterns of the viral genome in poliovirus type 2 isolated from paralytic patients. Infect Immun 1982;37:46-53. [DOI: 10.1128/iai.37.1.46-53.1982] [Cited by in Crossref: 36] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
8 Blomqvist S, Bruu A, Stenvik M, Hovi T. Characterization of a recombinant type 3/type 2 poliovirus isolated from a healthy vaccinee and containing a chimeric capsid protein VP1. Journal of General Virology 2003;84:573-80. [DOI: 10.1099/vir.0.18708-0] [Cited by in Crossref: 74] [Cited by in F6Publishing: 68] [Article Influence: 4.1] [Reference Citation Analysis]
9 Racaniello VR. Poliovirus neurovirulence. Adv Virus Res 1988;34:217-46. [PMID: 2843017 DOI: 10.1016/s0065-3527(08)60519-9] [Cited by in Crossref: 43] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
10 Cohen JI. Hepatitis A virus: insights from molecular biology. Hepatology 1989;9:889-95. [PMID: 2541060 DOI: 10.1002/hep.1840090617] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 0.8] [Reference Citation Analysis]
11 Emini EA, Leibowitz J, Diamond DC, Bonin J, Wimmer E. Recombinants of Mahoney and Sabin strain poliovirus type 1: analysis of in vitro phenotypic markers and evidence that resistance to guanidine maps in the nonstructural proteins. Virology 1984;137:74-85. [PMID: 6089422 DOI: 10.1016/0042-6822(84)90010-2] [Cited by in Crossref: 43] [Cited by in F6Publishing: 40] [Article Influence: 1.2] [Reference Citation Analysis]
12 Porter DC, Wang J, Moldoveanu Z, Mcpherson S, Morrow CD. Immunization of mice with poliovirus replicons expressing the C-fragment of tetanus toxin protects against lethal challenge with tetanus toxin. Vaccine 1997;15:257-64. [DOI: 10.1016/s0264-410x(96)00187-9] [Cited by in Crossref: 25] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
13 Chapman NM, Ramsingh AI, Tracy S. Genetics of coxsackievirus virulence. Curr Top Microbiol Immunol 1997;223:227-58. [PMID: 9294932 DOI: 10.1007/978-3-642-60687-8_11] [Cited by in Crossref: 10] [Cited by in F6Publishing: 17] [Article Influence: 0.4] [Reference Citation Analysis]
14 Hellen CUT, Wimmer E. Enterovirus Genetics. In: Rotbart HA, editor. Human Enterovirus Infections. Washington: ASM Press; 1995. pp. 25-72. [DOI: 10.1128/9781555818326.ch2] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 2.1] [Reference Citation Analysis]
15 Sen A, Saravanan P, Balamurugan V, Rajak KK, Sudhakar SB, Bhanuprakash V, Parida S, Singh RK. Vaccines against peste des petits ruminants virus. Expert Rev Vaccines 2010;9:785-96. [PMID: 20624051 DOI: 10.1586/erv.10.74] [Cited by in Crossref: 66] [Cited by in F6Publishing: 45] [Article Influence: 6.0] [Reference Citation Analysis]
16 De L, Nottay B, Yang CF, Holloway BP, Pallansch M, Kew O. Identification of vaccine-related polioviruses by hybridization with specific RNA probes. J Clin Microbiol 1995;33:562-71. [DOI: 10.1128/jcm.33.3.562-571.1995] [Cited by in Crossref: 49] [Cited by in F6Publishing: 23] [Article Influence: 1.9] [Reference Citation Analysis]
17 Horie H, Yoshida H, Matsuura K, Miyazawa M, Wakabayashi K, Nomoto A, Hashizume S. Isolation of vaccine-derived type 1 polioviruses displaying similar properties to virulent wild strain Mahoney from sewage in Japan. J Med Virol 2002;68:445-51. [DOI: 10.1002/jmv.10224] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 1.0] [Reference Citation Analysis]
18 Ellis RW, Provost PJ. Hepatitis B and A vaccines. In: Zuckerman AJ, editor. Recent Developments in Prophylactic Immunization. Dordrecht: Springer Netherlands; 1989. pp. 181-209. [DOI: 10.1007/978-94-009-1067-6_10] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
19 Duarte EA, Clarke DK, Moya A, Elena SF, Domingo E, Holland J. Many-trillionfold amplification of single RNA virus particles fails to overcome the Muller's ratchet effect. J Virol 1993;67:3620-3. [DOI: 10.1128/jvi.67.6.3620-3623.1993] [Cited by in Crossref: 56] [Cited by in F6Publishing: 25] [Article Influence: 2.0] [Reference Citation Analysis]
20 Mueller S, Wimmer E, Cello J. Poliovirus and poliomyelitis: a tale of guts, brains, and an accidental event. Virus Res 2005;111:175-93. [PMID: 15885840 DOI: 10.1016/j.virusres.2005.04.008] [Cited by in Crossref: 74] [Cited by in F6Publishing: 56] [Article Influence: 4.6] [Reference Citation Analysis]
21 Pelletier I, Duncan G, Colbère-Garapin F. One amino acid change on the capsid surface of poliovirus sabin 1 allows the establishment of persistent infections in HEp-2c cell cultures. Virology 1998;241:1-13. [PMID: 9454712 DOI: 10.1006/viro.1997.8954] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 1.0] [Reference Citation Analysis]
22 Freistadt MS, Eberle KE. Correlation between poliovirus type 1 Mahoney replication in blood cells and neurovirulence. J Virol 1996;70:6486-92. [DOI: 10.1128/jvi.70.9.6486-6492.1996] [Cited by in Crossref: 31] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
23 Ohka S, Yang WX, Terada E, Iwasaki K, Nomoto A. Retrograde transport of intact poliovirus through the axon via the fast transport system. Virology 1998;250:67-75. [PMID: 9770421 DOI: 10.1006/viro.1998.9360] [Cited by in Crossref: 83] [Cited by in F6Publishing: 70] [Article Influence: 3.6] [Reference Citation Analysis]
24 Toyoda H, Yang CF, Takeda N, Nomoto A, Wimmer E. Analysis of RNA synthesis of type 1 poliovirus by using an in vitro molecular genetic approach. J Virol 1987;61:2816-22. [DOI: 10.1128/jvi.61.9.2816-2822.1987] [Cited by in Crossref: 75] [Cited by in F6Publishing: 39] [Article Influence: 2.2] [Reference Citation Analysis]
25 Tardy-Panit M, Blondel B, Martin A, Tekaia F, Horaud F, Delpeyroux F. A mutation in the RNA polymerase of poliovirus type 1 contributes to attenuation in mice. J Virol 1993;67:4630-8. [PMID: 8392604 DOI: 10.1128/JVI.67.8.4630-4638.1993] [Cited by in Crossref: 46] [Cited by in F6Publishing: 28] [Article Influence: 1.6] [Reference Citation Analysis]
26 Savolainen-Kopra C, Blomqvist S. Mechanisms of genetic variation in polioviruses. Rev Med Virol 2010;20:358-71. [PMID: 20949639 DOI: 10.1002/rmv.663] [Cited by in Crossref: 43] [Cited by in F6Publishing: 34] [Article Influence: 4.3] [Reference Citation Analysis]
27 Porter DC, Melsen LR, Compans RW, Morrow CD. Release of virus-like particles from cells infected with poliovirus replicons which express human immunodeficiency virus type 1 Gag. J Virol 1996;70:2643-9. [DOI: 10.1128/jvi.70.4.2643-2649.1996] [Cited by in Crossref: 21] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
28 Toshiko O, Michinori K, Yuko S, Atsuko K, Nobumasa I, Akio N. Cloned infectious complementary DNA of the poliovirus Sabin 1 genome: biochemical and biological properties of the recovered virus. Gene 1984;32:1-10. [DOI: 10.1016/0378-1119(84)90026-x] [Cited by in Crossref: 45] [Cited by in F6Publishing: 17] [Article Influence: 1.2] [Reference Citation Analysis]
29 Ferguson M, Minor P, Spitz M, Yi-hua Q, Magrath D, Schild G. MONOCLONAL ANTIBODIES SPECIFIC FOR THE SABIN VACCINE STRAIN OF POLIOVIRUS 3. The Lancet 1982;320:122-4. [DOI: 10.1016/s0140-6736(82)91091-1] [Cited by in Crossref: 27] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
30 Gudding R, Van Muiswinkel WB. A history of fish vaccination. Fish & Shellfish Immunology 2013;35:1683-8. [DOI: 10.1016/j.fsi.2013.09.031] [Cited by in Crossref: 91] [Cited by in F6Publishing: 68] [Article Influence: 11.4] [Reference Citation Analysis]
31 Morrow CD, Novak MJ, Ansardi DC, Porter DC, Moldoveanu Z. Recombinant viruses as vectors for mucosal immunity. Curr Top Microbiol Immunol 1999;236:255-73. [PMID: 9893364 DOI: 10.1007/978-3-642-59951-4_13] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 0.4] [Reference Citation Analysis]
32 Pliaka V, Kyriakopoulou Z, Markoulatos P. Risks associated with the use of live-attenuated vaccine poliovirus strains and the strategies for control and eradication of paralytic poliomyelitis. Expert Rev Vaccines 2012;11:609-28. [PMID: 22827246 DOI: 10.1586/erv.12.28] [Cited by in Crossref: 43] [Cited by in F6Publishing: 28] [Article Influence: 4.8] [Reference Citation Analysis]
33 Viret J, Dietrich G, Favre D. Biosafety aspects of the recombinant live oral Vibrio cholerae vaccine strain CVD 103-HgR. Vaccine 2004;22:2457-69. [DOI: 10.1016/j.vaccine.2003.12.033] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 1.1] [Reference Citation Analysis]
34 Mallet L, Pelloquin F, Brigaud M, Caudrelier P, Bandet R, Xueref C, Fuchs F, Gibelin N, Goldman C, Moulin JC, de Fraipont F, Montagnon B, Peyron L, Aymard M. Comparative study of poliovirus excretion after vaccination of infants with two oral polio vaccines prepared on vero cells or on primary monkey kidney cells. J Med Virol 1997;52:50-60. [DOI: 10.1002/(sici)1096-9071(199705)52:1<50::aid-jmv9>3.0.co;2-q] [Cited by in Crossref: 12] [Article Influence: 0.5] [Reference Citation Analysis]
35 Lees CY, Briggs DJ, Wu X, Davis RD, Moore SM, Gordon C, Xiang Z, Ertl HC, Tang DC, Fu ZF. Induction of protective immunity by topic application of a recombinant adenovirus expressing rabies virus glycoprotein. Vet Microbiol 2002;85:295-303. [PMID: 11856579 DOI: 10.1016/s0378-1135(01)00523-5] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
36 Kew OM, Nottay BK, Rico-hesse R, Pallansch MA. Molecular Epidemiology of Wild Poliovirus Transmission. In: Kurstak E, Marusyk RG, Murphy FA, Van Regenmortel MHV, editors. Virus Variability, Epidemiology and Control. Boston: Springer US; 1990. pp. 199-221. [DOI: 10.1007/978-1-4757-9271-3_13] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
37 Nomoto A, Kitamura N, Lee JJ, Rothberg PG, Imura N, Wimmer E. Identification of point mutations in the genome of the poliovirus sabin vaccine LSc 2ab, and catalogue of RNase T1- and RNase A-resistant oligonucleotides of poliovirus type 1 (Mahoney) RNA. Virology 1981;112:217-27. [DOI: 10.1016/0042-6822(81)90627-9] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 0.6] [Reference Citation Analysis]
38 Ohara Y, Roos RP. Viral infectious complementary-DNA studies may identify nonviral genes critical to central nervous system disease. Ann Neurol 1989;25:305-9. [PMID: 2543264 DOI: 10.1002/ana.410250316] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
39 Pliaka V, Kyriakopoulou Z, Tsakogiannis D, Ruether IGA, Gartzonika C, Levidiotou-stefanou S, Krikelis A, Markoulatos P. Correlation of mutations and recombination with growth kinetics of poliovirus vaccine strains. Eur J Clin Microbiol Infect Dis 2010;29:1513-23. [DOI: 10.1007/s10096-010-1033-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
40 Combiescu M, Guillot S, Persu A, Baicus A, Pitigoi D, Balanant J, Oprisan G, Crainic R, Delpeyroux F, Aubert-combiescu A. Circulation of a type 1 recombinant vaccine-derived poliovirus strain in a limited area in Romania. Arch Virol 2007;152:727-38. [DOI: 10.1007/s00705-006-0884-y] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
41 Sutter RW, Kew OM, Cochi SL. Poliovirus vaccine-live. Vaccines. Elsevier; 2008. pp. 631-85. [DOI: 10.1016/b978-1-4160-3611-1.50030-1] [Cited by in Crossref: 24] [Article Influence: 1.8] [Reference Citation Analysis]
42 Marsden S, Boulger L, Magrath D, Reeve P, Schild G, Taffs L. Monkey neurovirulence of live, attenuated (Sabin) type I and type II poliovirus vaccines. Journal of Biological Standardization 1980;8:303-9. [DOI: 10.1016/s0092-1157(80)80008-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
43 Boone E, Albrecht P. Conventional and enhanced plaque neutralization assay for polio antibody. Journal of Virological Methods 1983;6:193-202. [DOI: 10.1016/0166-0934(83)90046-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.2] [Reference Citation Analysis]
44 Boulger L, Arya S, Ahourai P, Marsden S. International comparison of species of monkey used for the neurovirulence test for oral poliomyelitis vaccine. Journal of Biological Standardization 1978;6:233-42. [DOI: 10.1016/s0092-1157(78)80010-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
45 Sanders BP, Liu Y, Brandjes A, van Hoek V, de Los Rios Oakes I, Lewis J, Wimmer E, Custers JHHV, Schuitemaker H, Cello J, Edo-Matas D. Brunenders: a partially attenuated historic poliovirus type I vaccine strain. J Gen Virol 2015;96:2614-22. [PMID: 26018960 DOI: 10.1099/vir.0.000197] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
46 Minor P. Considerations for setting the specifications of vaccines. Expert Review of Vaccines 2014;11:579-85. [DOI: 10.1586/erv.12.23] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
47 Buttinelli G, Donati V, Fiore S, Marturano J, Plebani A, Balestri P, Soresina AR, Vivarelli R, Delpeyroux F, Martin J, Fiore L. Nucleotide variation in Sabin type 2 poliovirus from an immunodeficient patient with poliomyelitis. J Gen Virol 2003;84:1215-21. [PMID: 12692287 DOI: 10.1099/vir.0.18974-0] [Cited by in Crossref: 50] [Cited by in F6Publishing: 44] [Article Influence: 2.8] [Reference Citation Analysis]
48 Albrecht P, Enterline JC, Boone EJ, Klutch MJ. Poliovirus and polio antibody assay in HEp-2 and Vero cell cultures. J Biol Stand. 1983;11:91-97. [PMID: 6306012 DOI: 10.1016/S0092-1157(83)80031-6] [Cited by in Crossref: 22] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
49 Nomoto A. Recombinant Polioviruses as Candidates for Oral Live Poliovaccines. Microbiology and Immunology 1993;37:169-74. [DOI: 10.1111/j.1348-0421.1993.tb03196.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
50 Rico-hesse R, Pallansch MA, Nottay BK, Kew OM. Geographic distribution of wild poliovirus type 1 genotypes. Virology 1987;160:311-22. [DOI: 10.1016/0042-6822(87)90001-8] [Cited by in Crossref: 238] [Cited by in F6Publishing: 204] [Article Influence: 7.0] [Reference Citation Analysis]
51 Jackson CA, Messinger J, Palmer MT, Peduzzi JD, Morrow CD. Gene expression in the muscle and central nervous system following intramuscular inoculation of encapsidated or naked poliovirus replicons. Virology 2003;314:45-61. [DOI: 10.1016/s0042-6822(03)00385-4] [Cited by in Crossref: 12] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
52 Cohen JI. Toward understanding the molecular basis for attenuation of picornaviruses. Adv Virus Res 1989;36:153-80. [PMID: 2660495 DOI: 10.1016/s0065-3527(08)60584-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
53 Agol VI. Molecular mechanisms of poliovirus variation and evolution. Curr Top Microbiol Immunol 2006;299:211-59. [PMID: 16568901 DOI: 10.1007/3-540-26397-7_8] [Cited by in Crossref: 17] [Cited by in F6Publishing: 30] [Article Influence: 1.1] [Reference Citation Analysis]
54 Fu ZF, Rupprecht CE, Dietzschold B, Saikumar P, Niu HS, Babka I, Wunner WH, Koprowski H. Oral vaccination of racoons (Procyon lotor) with baculovirus-expressed rabies virus glycoprotein. Vaccine 1993;11:925-8. [DOI: 10.1016/0264-410x(93)90379-c] [Cited by in Crossref: 34] [Cited by in F6Publishing: 15] [Article Influence: 1.2] [Reference Citation Analysis]
55 Chumakov K, Ehrenfeld E, Wimmer E, Agol VI. Vaccination against polio should not be stopped. Nat Rev Microbiol 2007;5:952-8. [PMID: 17965726 DOI: 10.1038/nrmicro1769] [Cited by in Crossref: 60] [Cited by in F6Publishing: 41] [Article Influence: 4.3] [Reference Citation Analysis]
56 Macadam AI, Pollard SR, Ferguson G, Dunn G, Skuce R, Almond JW, Minor PD. The 5′ noncoding region of the type 2 poliovirus vaccine strain contains determinants of attenuation and temperature sensitivity. Virology 1991;181:451-8. [DOI: 10.1016/0042-6822(91)90877-e] [Cited by in Crossref: 82] [Cited by in F6Publishing: 35] [Article Influence: 2.7] [Reference Citation Analysis]
57 Svitkin YV, Cammack N, Minor PD, Almond JW. Translation deficiency of the Sabin type 3 poliovirus genome: association with an attenuating mutation C472----U. Virology 1990;175:103-9. [PMID: 2155504 DOI: 10.1016/0042-6822(90)90190-3] [Cited by in Crossref: 90] [Cited by in F6Publishing: 85] [Article Influence: 2.9] [Reference Citation Analysis]
58 Nomoto A, Koike S, Aoki J. Tissue tropism and species specificity of poliovirus infection. Trends Microbiol 1994;2:47-51. [PMID: 8162441 DOI: 10.1016/0966-842x(94)90125-2] [Cited by in Crossref: 28] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
59 Ohka S, Nomoto A. Recent insights into poliovirus pathogenesis. Trends in Microbiology 2001;9:501-6. [DOI: 10.1016/s0966-842x(01)02200-4] [Cited by in Crossref: 36] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
60 Chen-fu Y, De L, Su-ju Y, Gómez JR, Cruz J, Holloway BP, Pallansch MA, Kew OM. Genotype-specific in vitro amplification of sequences of the wild type 3 polioviruses from Mexico and Guatemala. Virus Research 1992;24:277-96. [DOI: 10.1016/0168-1702(92)90124-r] [Cited by in Crossref: 74] [Cited by in F6Publishing: 23] [Article Influence: 2.6] [Reference Citation Analysis]
61 Blomqvist S, Savolainen-Kopra C, Paananen A, El Bassioni L, El Maamoon Nasr EM, Firstova L, Zamiatina N, Kutateladze T, Roivainen M. Recurrent isolation of poliovirus 3 strains with chimeric capsid protein Vp1 suggests a recombination hot-spot site in Vp1. Virus Res 2010;151:246-51. [PMID: 20493912 DOI: 10.1016/j.virusres.2010.05.006] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
62 Nomoto A, Koike S. Molecular Mechanisms of Poliovirus Pathogenesis. In: Roos RP, editor. Molecular Neurovirology. Totowa: Humana Press; 1992. pp. 251-81. [DOI: 10.1007/978-1-4612-0407-7_6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
63 Niedrig M, Stolte N, Fuchs D, Hunsmann G, Stahl-hennig C. Intra-nasal infection of macaques with Yellow Fever (YF) vaccine strain 17D: a novel and economical approach for YF vaccination in man. Vaccine 1999;17:1206-10. [DOI: 10.1016/s0264-410x(98)00344-2] [Cited by in Crossref: 10] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
64 Plana-duran J, Bastons M, Rodriguez MJ, Climent I, Cortés E, Vela C, Casal I. Oral immunization of rabbits with VP60 particles confers protection against rabbit hemorrhagic disease. Archives of Virology 1996;141:1423-36. [DOI: 10.1007/bf01718245] [Cited by in Crossref: 39] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
65 Decroix N, Hocini H, Quan CP, Bellon B, Kazatchkine MD, Bouvet JP. Induction in mucosa of IgG and IgA antibodies against parenterally administered soluble immunogens. Scand J Immunol 2001;53:401-9. [PMID: 11285121 DOI: 10.1046/j.1365-3083.2001.00894.x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 1.1] [Reference Citation Analysis]
66 Blondel B, Colbere-garapin F, Couderc T, Wirotius A, Guivel-benhassine F. Poliovirus, Pathogenesis of Poliomyelitis, and Apoptosis. In: Griffin DE, editor. Role of Apoptosis in Infection. Berlin/Heidelberg: Springer-Verlag; 2005. pp. 25-56. [DOI: 10.1007/3-540-27320-4_2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 12] [Reference Citation Analysis]
67 Xin KW, Huimin Y, Alonso S. Enterovirus 71: pathogenesis, control and models of disease. Future Virology 2012;7:989-1004. [DOI: 10.2217/fvl.12.89] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
68 Park SW, Pons-Salort M, Messacar K, Cook C, Meyers L, Farrar J, Grenfell BT. Epidemiological dynamics of enterovirus D68 in the United States and implications for acute flaccid myelitis. Sci Transl Med 2021;13:eabd2400. [PMID: 33692131 DOI: 10.1126/scitranslmed.abd2400] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
69 Holland JJ, De La Torre JC, Steinhauer DA. RNA virus populations as quasispecies. Curr Top Microbiol Immunol 1992;176:1-20. [PMID: 1600747 DOI: 10.1007/978-3-642-77011-1_1] [Cited by in Crossref: 96] [Cited by in F6Publishing: 171] [Article Influence: 3.3] [Reference Citation Analysis]
70 Yang WX, Terasaki T, Shiroki K, Ohka S, Aoki J, Tanabe S, Nomura T, Terada E, Sugiyama Y, Nomoto A. Efficient delivery of circulating poliovirus to the central nervous system independently of poliovirus receptor. Virology 1997;229:421-8. [PMID: 9126254 DOI: 10.1006/viro.1997.8450] [Cited by in Crossref: 77] [Cited by in F6Publishing: 62] [Article Influence: 3.2] [Reference Citation Analysis]
71 Dowdle WR, De Gourville E, Kew OM, Pallansch MA, Wood DJ. Polio eradication: the OPV paradox. Rev Med Virol 2003;13:277-91. [DOI: 10.1002/rmv.401] [Cited by in Crossref: 94] [Cited by in F6Publishing: 71] [Article Influence: 5.2] [Reference Citation Analysis]
72 Boulger L, Marsden S, Magrath D, Taffs L, Schild G. Comparative monkey neurovirulence of sabin type III poliovirus vaccines. Journal of Biological Standardization 1979;7:97-111. [DOI: 10.1016/s0092-1157(79)80042-6] [Cited by in Crossref: 11] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
73 Sutter RW, Kew OM, Cochi SL, Aylward RB. Poliovirus Vaccine–Live. Plotkin's Vaccines. Elsevier; 2018. pp. 866-917.e16. [DOI: 10.1016/b978-0-323-35761-6.00048-1] [Cited by in Crossref: 5] [Article Influence: 1.7] [Reference Citation Analysis]
74 Ansardi DC, Porter DC, Anderson MJ, Morrow CD. Poliovirus Assembly and Encapsidation of Genomic RNA. Elsevier; 1996. pp. 1-68. [DOI: 10.1016/s0065-3527(08)60069-x] [Cited by in Crossref: 25] [Article Influence: 1.0] [Reference Citation Analysis]
75 Stanway G, Hughes PJ, Westrop GD, Evans DM, Dunn G, Minor PD, Schild GC, Almond JW. Construction of poliovirus intertypic recombinants by use of cDNA. J Virol 1986;57:1187-90. [DOI: 10.1128/jvi.57.3.1187-1190.1986] [Cited by in Crossref: 24] [Cited by in F6Publishing: 12] [Article Influence: 0.7] [Reference Citation Analysis]
76 Minor PD. Polio eradication, cessation of vaccination and re-emergence of disease. Nat Rev Microbiol 2004;2:473-82. [PMID: 15152203 DOI: 10.1038/nrmicro906] [Cited by in Crossref: 40] [Cited by in F6Publishing: 29] [Article Influence: 2.4] [Reference Citation Analysis]
77 Kitamura N, Semler BL, Rothberg PG, Larsen GR, Adler CJ, Dorner AJ, Emini EA, Hanecak R, Lee JJ, van der Werf S, Anderson CW, Wimmer E. Primary structure, gene organization and polypeptide expression of poliovirus RNA. Nature 1981;291:547-53. [PMID: 6264310 DOI: 10.1038/291547a0] [Cited by in Crossref: 637] [Cited by in F6Publishing: 617] [Article Influence: 15.9] [Reference Citation Analysis]
78 Stanway G, Cann AJ, Hauptmann R, Mountford RC, Clarke LD, Reeve P, Minor PD, Schild GC, Almond JW. Nucleic acid sequence of the region of the genome encoding capsid protein VP1 of neurovirulent and attenuated type 3 polioviruses. Eur J Biochem 1983;135:529-33. [PMID: 6311539 DOI: 10.1111/j.1432-1033.1983.tb07684.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.2] [Reference Citation Analysis]
79 Crainic R, Furione M, Otelea D, Guillot S, Balanant J, Aubert-combiescu A, Combiescu M, Candrea A. Natural evolution of oral vaccine poliovirus strains. In: Kurstak E, editor. Measles and Poliomyelitis. Vienna: Springer; 1993. pp. 371-90. [DOI: 10.1007/978-3-7091-9278-8_31] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
80 Racaniello VR, Ren R. Poliovirus Biology and Pathogenesis. In: Chisari FV, Oldstone MBA, editors. Transgenic Models of Human Viral and Immunological Disease. Berlin: Springer Berlin Heidelberg; 1996. pp. 305-25. [DOI: 10.1007/978-3-642-85208-4_15] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 0.2] [Reference Citation Analysis]
81 Elena SF, Sanjuán R, Bordería AV, Turner PE. Transmission bottlenecks and the evolution of fitness in rapidly evolving RNA viruses. Infect Genet Evol 2001;1:41-8. [PMID: 12798049 DOI: 10.1016/s1567-1348(01)00006-5] [Cited by in Crossref: 39] [Cited by in F6Publishing: 16] [Article Influence: 2.2] [Reference Citation Analysis]
82 Ahmed R, Chakraborty PR, Fields BN. Genetic variation during lytic reovirus infection: high-passage stocks of wild-type reovirus contain temperature-sensitive mutants. J Virol 1980;34:285-7. [DOI: 10.1128/jvi.34.1.285-287.1980] [Cited by in Crossref: 30] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
83 Georgescu MM, Tardy-panit M, Guillot S, Crainic R, Delpeyroux F. Mapping of mutations contributing to the temperature sensitivity of the Sabin 1 vaccine strain of poliovirus. J Virol 1995;69:5278-86. [DOI: 10.1128/jvi.69.9.5278-5286.1995] [Cited by in Crossref: 19] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
84 Minor PD. The polio-eradication programme and issues of the end game. J Gen Virol 2012;93:457-74. [PMID: 22128250 DOI: 10.1099/vir.0.036988-0] [Cited by in Crossref: 40] [Cited by in F6Publishing: 26] [Article Influence: 4.0] [Reference Citation Analysis]
85 Boulger L, Magrath D. Differing neurovirulence of three Sabin attenuated type 3 vaccine seed pools and their progeny. Journal of Biological Standardization 1973;1:139-47. [DOI: 10.1016/0092-1157(73)90050-4] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 0.3] [Reference Citation Analysis]
86 Thomassen YE, van Eikenhorst G, van der Pol LA, Bakker WAM. Isoelectric Point Determination of Live Polioviruses by Capillary Isoelectric Focusing with Whole Column Imaging Detection. Anal Chem 2013;85:6089-94. [DOI: 10.1021/ac400968q] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 1.9] [Reference Citation Analysis]
87 Bouchard MJ, Lam DH, Racaniello VR. Determinants of attenuation and temperature sensitivity in the type 1 poliovirus Sabin vaccine. J Virol 1995;69:4972-8. [DOI: 10.1128/jvi.69.8.4972-4978.1995] [Cited by in Crossref: 109] [Cited by in F6Publishing: 52] [Article Influence: 4.2] [Reference Citation Analysis]
88 Lee C, Young C. Murine neurovirulence studies with a chimeric poliovirus:in vivogeneration of a mutant base-paired stable attenuated poliovirus. Microbial Pathogenesis 1998;25:215-25. [DOI: 10.1006/mpat.1998.0231] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
89 Kohara M, Abe S, Kuge S, Semler BL, Komatsu T, Arita M, Itoh H, Nomoto A. An Infectious cDNA clone of the poliovirus sabin strain could be used as a stable repository and inoculum for the oral polio live vaccine. Virology 1986;151:21-30. [DOI: 10.1016/0042-6822(86)90100-5] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 1.0] [Reference Citation Analysis]
90 Muzychenko AR, Lipskaya GY, Maslova SV, Svitkin YV, Pilipenko EV, Nottay BK, Kew OM, Agol VI. Coupled mutations in the 5'-untranslated region of the Sabin poliovirus strains during in vivo passages: structural and functional implications. Virus Research 1991;21:111-22. [DOI: 10.1016/0168-1702(91)90002-d] [Cited by in Crossref: 36] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
91 Tracy S, Chapman NM, Drescher KM, Kono K, Tapprich W. Evolution of virulence in picornaviruses. Curr Top Microbiol Immunol 2006;299:193-209. [PMID: 16568900 DOI: 10.1007/3-540-26397-7_7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 19] [Article Influence: 0.5] [Reference Citation Analysis]
92 Ellis RW. New technologies for making vaccines. Vaccine 1999;17:1596-604. [DOI: 10.1016/s0264-410x(98)00416-2] [Cited by in Crossref: 30] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
93 Yates MV. Enterovirus. Microbiology of Waterborne Diseases. Elsevier; 2014. pp. 493-504. [DOI: 10.1016/b978-0-12-415846-7.00025-1] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
94 Hamidi A, Bakker WA. Innovative IPV from attenuated Sabin poliovirus or newly designed alternative seed strains. Pharm Pat Anal 2012;1:589-99. [PMID: 24236927 DOI: 10.4155/ppa.12.70] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
95 Novak MJ, Smythies LE, McPherson SA, Smith PD, Morrow CD. Poliovirus replicons encoding the B subunit of Helicobacter pylori urease elicit a Th1 associated immune response. Vaccine. 1999;17:2384-2391. [PMID: 10392620 DOI: 10.1016/s0264-410x(99)00035-3] [Cited by in Crossref: 23] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
96 Agol VI. Vaccine-derived polioviruses. Biologicals 2006;34:103-8. [PMID: 16650771 DOI: 10.1016/j.biologicals.2006.02.007] [Cited by in Crossref: 49] [Cited by in F6Publishing: 40] [Article Influence: 3.3] [Reference Citation Analysis]
97 Omata T, Kohara M, Kuge S, Komatsu T, Abe S, Semler BL, Kameda A, Itoh H, Arita M, Wimmer E. Genetic analysis of the attenuation phenotype of poliovirus type 1. J Virol 1986;58:348-58. [DOI: 10.1128/jvi.58.2.348-358.1986] [Cited by in Crossref: 156] [Cited by in F6Publishing: 72] [Article Influence: 4.5] [Reference Citation Analysis]
98 Singer C, Knauert F, Bushar G, Klutch M, Lundquist R, Quinnan GV. Quantitation of poliovirus antigens in inactivated viral vaccines by enzyme-linked immunosorbent assay using animal sera and monoclonal antibodies. Journal of Biological Standardization 1989;17:137-50. [DOI: 10.1016/0092-1157(89)90004-8] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 0.7] [Reference Citation Analysis]
99 Kajigaya S, Arakawa H, Kuge S, Koi T, Imura N, Nomoto A. Isolation and characterization of defective-interfering particles of poliovirus Sabin 1 strain. Virology 1985;142:307-16. [PMID: 2997988 DOI: 10.1016/0042-6822(85)90339-3] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 1.0] [Reference Citation Analysis]
100 Ahmed SS, Ellis RW, Rappuoli R. Technologies for Making New Vaccines. Plotkin's Vaccines. Elsevier; 2018. pp. 1283-1304.e7. [DOI: 10.1016/b978-0-323-35761-6.00066-3] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
101 Minor PD, Schild GC, Bootman J, Evans DM, Ferguson M, Reeve P, Spitz M, Stanway G, Cann AJ, Hauptmann R, Clarke LD, Mountford RC, Almond JW. Location and primary structure of a major antigenic site for poliovirus neutralization. Nature 1983;301:674-9. [PMID: 6186919 DOI: 10.1038/301674a0] [Cited by in Crossref: 139] [Cited by in F6Publishing: 119] [Article Influence: 3.7] [Reference Citation Analysis]
102 Almond JW, Westrop GD, Evans DM, Dunn G, Minor PD, Magrath D, Schild GC. Studies on the attenuation of the Sabin type 3 oral polio vaccine. J Virol Methods 1987;17:183-9. [PMID: 2822753 DOI: 10.1016/0166-0934(87)90081-4] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 0.5] [Reference Citation Analysis]
103 Pelletier I, Couderc T, Borzakian S, Wyckoff E, Crainic R, Ehrenfeld E, Colbere-garapin F. Characterization of persistent poliovirus mutants selected in human neuroblastoma cells. Virology 1991;180:729-37. [DOI: 10.1016/0042-6822(91)90086-q] [Cited by in Crossref: 35] [Cited by in F6Publishing: 3] [Article Influence: 1.2] [Reference Citation Analysis]
104 Evans DJ, Almond JW. Design, construction, and characterization of poliovirus antigen chimeras. Methods Enzymol 1991;203:386-400. [PMID: 1662331 DOI: 10.1016/0076-6879(91)03022-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.2] [Reference Citation Analysis]
105 Christodoulou C, Colbere-garapin F, Macadam A, Taffs LF, Marsden S, Minor P, Horaud F. Mapping of mutations associated with neurovirulence in monkeys infected with Sabin 1 poliovirus revertants selected at high temperature. J Virol 1990;64:4922-9. [DOI: 10.1128/jvi.64.10.4922-4929.1990] [Cited by in Crossref: 81] [Cited by in F6Publishing: 31] [Article Influence: 2.6] [Reference Citation Analysis]
106 Minor P, Macadam A, Cammack N, Dunn G, Almond J. Molecular biology and the control of viral vaccines. FEMS Microbiology Letters 1990;64:207-13. [DOI: 10.1111/j.1574-6968.1990.tb03521.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.2] [Reference Citation Analysis]
107 Dowdle W, Van Der Avoort H, De Gourville E, Delpeyroux F, Desphande J, Hovi T, Martin J, Pallansch M, Kew O, Wolff C. Containment of Polioviruses After Eradication and OPV Cessation: Characterizing Risks to Improve Management. Risk Analysis 2006;26:1449-69. [DOI: 10.1111/j.1539-6924.2006.00844.x] [Cited by in Crossref: 46] [Cited by in F6Publishing: 39] [Article Influence: 3.1] [Reference Citation Analysis]
108 Kim KS, Hufnagel G, Chapman NM, Tracy S. The group B coxsackieviruses and myocarditis. Rev Med Virol 2001;11:355-68. [PMID: 11746998 DOI: 10.1002/rmv.326] [Cited by in Crossref: 111] [Cited by in F6Publishing: 87] [Article Influence: 5.8] [Reference Citation Analysis]
109 Rezapkin GV, Douthitt M, Dragunsky E, Chumakov KM. Reevaluation of nucleotide sequences of wild-type and attenuated polioviruses of type 3. Virus Res 1999;65:111-9. [PMID: 10581384 DOI: 10.1016/s0168-1702(99)00108-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
110 Morrow CD, Moldoveanu Z, Anderson MJ, Porter DC. Poliovirus Replicons as a Vector for Mucosal Vaccines. Mucosal Vaccines. Elsevier; 1996. pp. 137-46. [DOI: 10.1016/b978-012410580-5/50011-x] [Cited by in Crossref: 1] [Article Influence: 0.0] [Reference Citation Analysis]
111 Minor PD. Live attenuated vaccines: Historical successes and current challenges. Virology 2015;479-480:379-92. [PMID: 25864107 DOI: 10.1016/j.virol.2015.03.032] [Cited by in Crossref: 177] [Cited by in F6Publishing: 143] [Article Influence: 29.5] [Reference Citation Analysis]
112 Svitkin YV, Pestova TV, Maslova SV, Agol VI. Point mutations modify the response of poliovirus RNA to a translation initiation factor: A comparison of neurovirulent and attenuated strains. Virology 1988;166:394-404. [DOI: 10.1016/0042-6822(88)90510-7] [Cited by in Crossref: 96] [Cited by in F6Publishing: 100] [Article Influence: 2.9] [Reference Citation Analysis]
113 Chen-fu Y, De L, Holloway BP, Pallansch MA, Kew OM. Detection and identification of vaccine-related polioviruses by the polymerase chain reaction. Virus Research 1991;20:159-79. [DOI: 10.1016/0168-1702(91)90107-7] [Cited by in Crossref: 82] [Cited by in F6Publishing: 68] [Article Influence: 2.7] [Reference Citation Analysis]
114 Koike S, Nagata N. A Transgenic Mouse Model of Poliomyelitis. Methods Mol Biol 2016;1387:129-44. [PMID: 26983733 DOI: 10.1007/978-1-4939-3292-4_7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
115 Chao L. Evolution of sex in RNA viruses. Journal of Theoretical Biology 1988;133:99-112. [DOI: 10.1016/s0022-5193(88)80027-4] [Cited by in Crossref: 70] [Cited by in F6Publishing: 25] [Article Influence: 2.1] [Reference Citation Analysis]
116 Duchene M, Peetermans J, D′hondt E, Harford N, Fabry L, Stephenne J. Production of Poliovirus Vaccines: Past, Present, and Future. Viral Immunology 1990;3:243-72. [DOI: 10.1089/vim.1990.3.243] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 0.7] [Reference Citation Analysis]
117 Yoshii K, Matsukura T, Nakano M, Tagaya I. Pattern of plaquing efficiency at different temperatures (PPET) as a differentiation tool among poliovirus type 3 Leon 12a1b progenies and its possible use as a genetic marker. J Biol Stand 1979;7:169-78. [PMID: 227907 DOI: 10.1016/s0092-1157(79)80020-7] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
118 Nottay BK, Kew OM, Hatch MH, Heyward JT, Obijeski JF. Molecular variation of type 1 vaccine-related and wild polioviruses during replication in humans. Virology 1981;108:405-23. [DOI: 10.1016/0042-6822(81)90448-7] [Cited by in Crossref: 134] [Cited by in F6Publishing: 113] [Article Influence: 3.4] [Reference Citation Analysis]
119 Levin BR, Bull JJ. Short-sighted evolution and the virulence of pathogenic microorganisms. Trends Microbiol 1994;2:76-81. [PMID: 8156275 DOI: 10.1016/0966-842x(94)90538-x] [Cited by in Crossref: 231] [Cited by in F6Publishing: 87] [Article Influence: 8.6] [Reference Citation Analysis]
120 Burke KL, Dunn G, Ferguson M, Minor PD, Almond JW. Antigen chimaeras of poliovirus as potential new vaccines. Nature 1988;332:81-2. [PMID: 2450279 DOI: 10.1038/332081a0] [Cited by in Crossref: 131] [Cited by in F6Publishing: 111] [Article Influence: 4.0] [Reference Citation Analysis]
121 Macadam A, Ferguson G, Burlison J, Stone D, Skuce R, Almond J, Minor P. Correlation of RNA secondary structure and attenuation of Sabin vaccine strains of poliovirus in tissue culture. Virology 1992;189:415-22. [DOI: 10.1016/0042-6822(92)90565-7] [Cited by in Crossref: 46] [Cited by in F6Publishing: 43] [Article Influence: 1.6] [Reference Citation Analysis]
122 Moldoveanu Z, Porter DC, Lu A, Mcpherson S, Morrow CD. Immune responses induced by administration of encapsidated poliovirus replicons which express HIV-1 gag and envelope proteins. Vaccine 1995;13:1013-22. [DOI: 10.1016/0264-410x(95)00018-v] [Cited by in Crossref: 33] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
123 Malnou CE, Werner A, Borman AM, Westhof E, Kean KM. Effects of Vaccine Strain Mutations in Domain V of the Internal Ribosome Entry Segment Compared in the Wild Type Poliovirus Type 1 Context. Journal of Biological Chemistry 2004;279:10261-9. [DOI: 10.1074/jbc.m307806200] [Cited by in Crossref: 16] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
124 Vetter V, Denizer G, Friedland LR, Krishnan J, Shapiro M. Understanding modern-day vaccines: what you need to know. Annals of Medicine 2018;50:110-20. [DOI: 10.1080/07853890.2017.1407035] [Cited by in Crossref: 90] [Cited by in F6Publishing: 57] [Article Influence: 22.5] [Reference Citation Analysis]
125 Sutter RW, Kew OM, Cochi SL, Aylward RB. Poliovirus vaccine—live. Vaccines. Elsevier; 2013. pp. 598-645. [DOI: 10.1016/b978-1-4557-0090-5.00035-5] [Cited by in Crossref: 36] [Article Influence: 4.5] [Reference Citation Analysis]
126 Horaud F, Crainic R, Blondel B. Polio vaccine: From empiricism and efficacyto scientific knowledge. Annales de l'Institut Pasteur / Virologie 1985;136:527-45. [DOI: 10.1016/s0769-2617(85)80144-1] [Cited by in Crossref: 3] [Article Influence: 0.1] [Reference Citation Analysis]
127 Macadam A, Arnold C, Howlett J, John A, Marsden S, Taffs F, Reeve P, Hamada N, Wareham K, Almond J, Cammack N, Minor P. Reversion of the attenuated and temperature-sensitive phenotypes of the sabin type 3 strain of poliovirus in vaccinees. Virology 1989;172:408-14. [DOI: 10.1016/0042-6822(89)90183-9] [Cited by in Crossref: 101] [Cited by in F6Publishing: 76] [Article Influence: 3.2] [Reference Citation Analysis]
128 Dunn G, Begg NT, Cammack N, Minor PD. Virus excretion and mutation by infants following primary vaccination with live oral poliovaccine from two sources. J Med Virol 1990;32:92-5. [PMID: 2177777 DOI: 10.1002/jmv.1890320205] [Cited by in Crossref: 61] [Cited by in F6Publishing: 49] [Article Influence: 2.0] [Reference Citation Analysis]
129 Lee C, Kono K, Haas E, Kim K, Drescher KM, Chapman NM, Tracy S. Characterization of an infectious cDNA copy of the genome of a naturally occurring, avirulent coxsackievirus B3 clinical isolate. Journal of General Virology 2005;86:197-210. [DOI: 10.1099/vir.0.80424-0] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 1.8] [Reference Citation Analysis]
130 Holland JJ. Transitions in understanding of RNA viruses: a historical perspective. Curr Top Microbiol Immunol 2006;299:371-401. [PMID: 16568907 DOI: 10.1007/3-540-26397-7_14] [Cited by in Crossref: 7] [Cited by in F6Publishing: 12] [Article Influence: 0.5] [Reference Citation Analysis]
131 Fields BN, Greene MI. Genetic and molecular mechanisms of viral pathogenesis: implications for prevention and treatment. Nature 1982;300:19-23. [PMID: 6290894 DOI: 10.1038/300019a0] [Cited by in Crossref: 101] [Cited by in F6Publishing: 81] [Article Influence: 2.6] [Reference Citation Analysis]
132 Ellis RW. Technologies for the design, discovery, formulation and administration of vaccines. Vaccine 2001;19:2681-7. [PMID: 11257409 DOI: 10.1016/s0264-410x(00)00504-1] [Cited by in Crossref: 28] [Cited by in F6Publishing: 3] [Article Influence: 1.4] [Reference Citation Analysis]
133 Bull JJ. VIRULENCE. Evolution 1994;48:1423-37. [PMID: 28568406 DOI: 10.1111/j.1558-5646.1994.tb02185.x] [Cited by in Crossref: 45] [Cited by in F6Publishing: 111] [Article Influence: 11.3] [Reference Citation Analysis]
134 Balanant J, Guillot S, Candrea A, Delpeyroux F, Crainic R. The natural genomic variability of poliovirus analyzed by a restriction fragment length polymorphism assay. Virology 1991;184:645-54. [DOI: 10.1016/0042-6822(91)90434-d] [Cited by in Crossref: 121] [Cited by in F6Publishing: 40] [Article Influence: 4.0] [Reference Citation Analysis]
135 Nomoto A, Arita I. Eradication of Poliomyelitis. Nat Immunol 2002;3:205-8. [DOI: 10.1038/ni0302-205] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]